1. Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy.
- Author
-
Bahrmann P, Rach J, Desch S, Schuler GC, and Thiele H
- Subjects
- Aged, Aged, 80 and over, Angina, Unstable etiology, Angina, Unstable mortality, Biomarkers blood, Cardiovascular Agents adverse effects, Chi-Square Distribution, Coronary Angiography, Coronary Occlusion diagnostic imaging, Coronary Occlusion mortality, Coronary Occlusion physiopathology, Creatine Kinase, MB Form blood, Female, Germany, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Myocardial Infarction diagnostic imaging, Myocardial Infarction mortality, Myocardial Infarction physiopathology, Myocardium enzymology, Myocardium pathology, Proportional Hazards Models, Prospective Studies, Recurrence, Risk Assessment, Risk Factors, Stents, Stroke Volume, Time Factors, Treatment Outcome, Ventricular Function, Left, Angioplasty, Balloon, Coronary adverse effects, Angioplasty, Balloon, Coronary instrumentation, Angioplasty, Balloon, Coronary mortality, Cardiovascular Agents therapeutic use, Collateral Circulation, Coronary Artery Bypass adverse effects, Coronary Artery Bypass mortality, Coronary Circulation, Coronary Occlusion therapy, Myocardial Infarction therapy
- Abstract
Background: It is assumed that patients with non-ST-elevation myocardial infarctions (NSTEMI) showing an infero- or posterolateral occluded culprit artery (OCA) during diagnostic angiography frequently elude standard 12-lead electrocardiogram diagnosis. In addition, coronary collaterals may have beneficial effects in patients with OCA., Methods: We examined 448 consecutive NSTEMI patients within 72 h of symptom onset. All patients underwent early invasive angiography plus optimal medical therapy. We compared clinical characteristics and 30-days/6-month major adverse cardiovascular events (MACE) between patients with OCA and non-OCA. The secondary objective was to investigate the effect of angiographically visible coronary collaterals on 6-month MACE in patients with OCA., Results: The angiograms revealed OCA in 130 (29%) of 448 patients. Patients with OCA showed more often infero- or posterolateral lesions (75 vs. 53%, p < 0.001) and more collaterals (57 vs. 8%, p < 0.001) compared with those with non-OCA. Patients with OCA had larger infarcts (peak CK-MB 2.1 ± 2.3 vs. 1.2 ± 1.1 μmol/L/s, p < 0.001), lower left ventricular ejection fraction (42 ± 21 vs. 48 ± 20%, p = 0.01), were more often revascularized (89 vs. 78%, p = 0.005), and had higher risk-adjusted 6-month MACE largely driven by its association with non-fatal reinfarctions (HR 2.16, 95% CI 1.04-4.50, p = 0.04). Patients with OCA and angiographically absent collaterals had significantly higher risk-adjusted 6-month MACE than those with OCA and angiographically visible collaterals (HR 1.96, 95% CI 1.02-3.76, p = 0.04)., Conclusions: Approximately one-fourth of patients with NSTEMI revealed OCA that was more frequently found in coronary arteries supplying the infero- or posterolateral myocardium. Patients with OCA had larger infarcts and more non-fatal reinfarctions than patients with non-OCA. Well-developed collaterals may limit the myocardial damage in these patients.
- Published
- 2011
- Full Text
- View/download PDF